Skip to content
10-Q

Quarterly Report

MediXall Group, Inc.

0001079973-25-000902

← back to feed
Filed
May 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 9, 2025 204.86M sh
Shares Diluted Q1 2024 · Mar 31, 2024 134.04M sh
Shares Diluted Q1 2024 · Mar 31, 2023 122.19M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$308.85K
Operating Cash Flow restated Q1 2024 · Mar 31, 2023 −$448.34K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$7.01M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$6.52M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$4.37M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$3.67M
Current Liabilities Q1 2024 · Mar 31, 2024 $7.22M
Current Liabilities Q1 2024 · Dec 31, 2023 $6.7M
Total Liabilities Q1 2024 · Mar 31, 2024 $7.28M
Total Liabilities Q1 2024 · Dec 31, 2023 $6.72M
Current Assets Q1 2024 · Mar 31, 2024 $72.09K
Current Assets Q1 2024 · Dec 31, 2023 $14.21K
Total Assets Q1 2024 · Mar 31, 2024 $271.73K
Total Assets Q1 2024 · Dec 31, 2023 $201.1K
Eps Diluted Q1 2024 · Mar 31, 2024 $0.00
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.01
Eps Basic Q1 2024 · Mar 31, 2024 $0.00
Eps Basic Q1 2024 · Mar 31, 2023 −$0.01
Net Income Q1 2024 · Mar 31, 2024 −$486.6K
Net Income Q1 2024 · Mar 31, 2023 −$1.22M
Gross Profit Q1 2024 · Mar 31, 2024 $67.73K
Gross Profit Q1 2024 · Mar 31, 2023 −$11.54K
Cost Of Revenue Q1 2024 · Mar 31, 2024 $50.41K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $89.4K
Revenue Q1 2024 · Mar 31, 2024 $118.14K
Revenue Q1 2024 · Mar 31, 2023 $77.87K